Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Autor: Collinson F; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Royle KL; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Swain J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ralph C; Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK., Maraveyas A; Academic Oncology, Faculty of Health Sciences, Hull York Medical School, Queens Centre Oncology and Haematology, Hull, UK., Eisen T; Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Nathan P; Department of Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Hertfordshire, UK., Jones R; School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Meads D; Academic Unit of Health Economics, University of Leeds, Leeds, UK., Min Wah T; Department of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals Trust, Leeds, UK., Martin A; Academic Unit of Health Economics, University of Leeds, Leeds, UK., Bestall J; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Kelly-Morland C; Department of Cancer Imaging, King's College London, London, UK., Linsley C; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Oughton J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Chan K; Medical Oncology, Weston Park Cancer Hospital, Sheffield, UK., Theodoulou E; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Arias-Pinilla G; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Kwan A; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., Daverede L; Department of Clinical Oncology, Austral University Hospital, Buenos Aires, Argentina., Handforth C; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Trainor S; St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Salawu A; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., McCabe C; Institute of Health Economics, University of Alberta, Edmonton, Canada., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Buckley D; Faculty of Medicine and Health, School of Medicine, University of Leeds, Leeds, UK., Hewison J; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Gregory W; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Selby P; Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK., Brown J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Brown J; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK.

Publikováno v: Health technology assessment (Winchester, England) [Health Technol Assess] 2024 Aug; Vol. 28 (45), pp. 1-171.